Antacid Cancer Lawsuit: Your NY Legal Rights

The antacid cancer lawsuits primarily involve ranitidine (Zantac), which the FDA recalled in 2020 after finding it contained NDMA, a probable human carcinogen. Plaintiffs allege that manufacturers knew or should have known the drug degraded into dangerous levels of NDMA and failed to warn consumers. Cases involve claims of stomach cancer, bladder cancer, colorectal cancer, and other NDMA-linked cancers.

New York residents who took ranitidine (Zantac) or other NDMA-contaminated antacids for a sustained period and were later diagnosed with a cancer linked to NDMA exposure may qualify to file a claim. Eligibility depends on the duration of use, dosage, cancer type, and the timing of your diagnosis relative to your antacid use. An attorney can evaluate whether your specific facts support a viable product liability claim.

Under CPLR §214, New York generally imposes a 3-year statute of limitations for personal injury claims, including product liability cases. The clock typically starts when you knew or should have known your cancer was linked to antacid use. Because the discovery rule can be complex to apply, you should consult a NY attorney as soon as possible to protect your right to sue.

New York plaintiffs in antacid cancer cases may seek compensation for medical expenses, lost wages, pain and suffering, and reduced quality of life. Wrongful death claims are also available for families who lost a loved one to an NDMA-linked cancer. No outcome is guaranteed, and results depend on the specific facts of your case, so speaking with an experienced NY product liability attorney is the critical first step.

The Zantac litigation has gone through significant changes. In 2022, the federal MDL was effectively ended when the presiding judge excluded plaintiffs' expert witnesses, which collapsed most of the federal cases. However, litigation continues in a number of state courts, where judges have reached different conclusions about the admissibility of expert testimony linking ranitidine to cancer.rnIf you were diagnosed with cancer after long-term Zantac use, the viability of your claim depends heavily on which court would hear it and the current status of litigation in that jurisdiction. Because the landscape continues to shift, having your specific situation evaluated by an attorney promptly is essential — both to understand your options and to preserve any applicable deadlines.